Pharmacogenetics [7] (multiple letters)

New England Journal of Medicine

Volumn 348, Issue 20, 2003, Pages 2041-2043

  Padrini, Roberto ^a   Ferrari, Mariano ^a   Carnes, Molly ^b   Noah, Lars ^c   Weinshilboum, Richard ^d   Evans, William E ^e   McLeod, Howard L ^f   Goldstein, David B ^g   Vallance, Patrick ^g  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d MAYO CLINIC   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOCHROME P450 2C9; DIHYDROPYRIMIDINASE; FLUOROURACIL; WARFARIN; DRUG; ENZYME;

DECISION MAKING; DRUG CLEARANCE; DRUG DISPOSITION; DRUG METABOLISM; ENZYME METABOLISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INDIVIDUALIZATION; LETTER; PHARMACOGENETICS; PRIORITY JOURNAL; RISK FACTOR; WILD TYPE; DRUG INDUSTRY; ECONOMICS; HEALTH INSURANCE; NOTE; DRUG THERAPY; FEMALE; GENETIC POLYMORPHISM; MALE; METABOLISM; PHARMACOKINETICS; SEXUAL DEVELOPMENT;

DRUG INDUSTRY; HUMANS; INSURANCE, HEALTH; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; DRUG THERAPY; FEMALE; MALE; PHARMACOKINETICS; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS; ENZYMES;

EID: 0038445500     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200305153482023     Document Type: Letter

References (0)